InBioGen Co Ltd Cash Flow Quality Index
InBioGen Co Ltd cash flow quality index. InBioGen Co Ltd (101140) has a Cash Flow Quality Index of -0.20x as of September 2025. Operating cash flow of ₩-1.67 Billion is below net income of ₩8.17 Billion, suggesting accrual-heavy earnings not yet converted to cash. See InBioGen Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of InBioGen Co Ltd (2018–2024)
Cash flow quality index of InBioGen Co Ltd from 2018 to 2024. Historical Cash Flow Quality Index for InBioGen Co Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore InBioGen Co Ltd (101140) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
InBioGen Co Ltd Cash Flow Quality Index by Year (2018–2024)
InBioGen Co Ltd cash flow quality index by year from 2018 to 2024. Year-by-year earnings quality comparison for InBioGen Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of InBioGen Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | ₩-33.13 Million | ₩16.12 Billion | ▲ +97.8% |
| 2023 | -0.09x | ₩-1.05 Billion | ₩11.34 Billion | ▼ -23.3% |
| 2021 | -0.08x | ₩-7.07 Billion | ₩94.12 Billion | ▲ +74.3% |
| 2019 | -0.29x | ₩-3.83 Billion | ₩13.12 Billion | ▲ +71.4% |
| 2018 | -1.02x | ₩-1.70 Billion | ₩1.66 Billion | — |